Scientists scan brains to unlock mystery of bipolar depression drug
NCT ID NCT05060549
Summary
This study aims to understand how the medication cariprazine (Vraylar) helps people with bipolar depression. Eight adults with the condition will take the drug and have special brain scans (PET scans) before and during treatment. Researchers will look at how the drug interacts with a specific brain receptor to learn more about its antidepressant effects.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BIPOLAR DEPRESSION are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Columbia University Medical Center
New York, New York, 10032, United States
Conditions
Explore the condition pages connected to this study.